GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment. Nuermberger EL, Martinez-Martinez MS, Sanz O, Urones B, et al. Antimicrob Agents Chemother 2022 May 24:e0013222. doi: 10.1128/aac.00132.

Read + Share

Amedeo Smart

Independent Medical Education

Nuermberger EL, Martinez-Martinez MS, Sanz O, Urones B, et al. GSK2556286 Is a Novel Antitubercular Drug Candidate Effective In Vivo with the Potential To Shorten Tuberculosis Treatment. Antimicrob Agents Chemother 2022 May 24:e0013222. doi: 10.1128/aac.00132.
PMID: 35607978